Redeye revisits LIDDS following a change of analyst, a change of company CEO, and the outcome of a newly conducted rights issue. We endorse the company’s robust new focus on the business development of its portfolio, which should establish LIDDS in an encouraging position to seal a licensing deal in 2023.